12 Best Depressed Stocks to Buy in 2025

4. Elevance Health, Inc. (NYSE:ELV)

52 Week Range: $273.73-$567.26

Current Share Price: $274.41

Stock Upside Potential: 32.46%

Market Cap: $662.24 Billion

Number of Hedge Fund Holders: 75

Elevance Health, Inc. (NYSE:ELV) is one of the best depressed stocks to buy in 2025. On July 28, UBS reiterated a ‘Buy’ rating on the stock and a $435 price target. The positive stance follows the healthcare company’s second-quarter results.

The healthcare company delivered adjusted earnings per share of $8.84, in line with consensus estimates. It also delivered $49.8 billion in revenues, beating expectations by 2.8%. Nevertheless, the company reduced its earnings per share outlook by $4.50, resulting in a $1.3 billion decrease in pretax income. Elevance also increased its 2025 medical loss ratio expectations by 90 basis points.

Elevance attributes the higher medical loss expectations to worse-than-expected cost trends in the Affordable Care Act exchange and Medicaid businesses. UBS maintains a Buy rating on the stock, citing potential earnings stability and growth in the commercial and Carelon segments.

Elevance Health, Inc. (NYSE:ELV) is a healthcare company dedicated to enhancing the health of individuals and communities. It offers a range of services, including health plans, clinical solutions, behavioral health, pharmacy benefits, and complex care solutions.